Literature DB >> 1727822

C-peptide suppression test: effects of gender, age, and body mass index; implications for the diagnosis of insulinoma.

F J Service1, P C O'Brien, P C Kao, W F Young.   

Abstract

To assess the effects of gender, age, and body mass index (BMI) on suppression of plasma C-peptide during insulin-induced hypoglycemia, 101 lean and obese, healthy men and women ages 20 to 80 yr underwent infusion of human regular insulin, 0.125 U/kg over 60 min after an overnight fast. Plasma glucose, insulin, and C-peptide were measured every 30 min for 120 min. C-peptide concentrations were influenced by gender at 30 min, by BMI at baseline and both BMI and age at all subsequent time points. Because of variations in baseline plasma C-peptide concentrations, percent decrease in C-peptide was evaluated. Significantly less percent decrease of C-peptide with increased age at 30, 60, and 90 min and with increased BMI at 30 and 60 min were noted with no effect of gender. From stepwise regression analysis using multiple, additional variables only the plasma glucose concentration at 30 min made a significant, albeit small (8%), contribution to the variability in percent decrease in C-peptide at 60 min. When C-peptide responses from eight histologically confirmed insulinoma patients were contrasted to values adjusted for age, gender, and BMI of normal subjects, all insulinoma patients had abnormal responses when percent decrease in C-peptide was used, whereas only four insulinoma patients had abnormal response when actual C-peptide concentrations were used.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1727822     DOI: 10.1210/jcem.74.1.1727822

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

1.  Sex- and season-dependent differences in C-peptide levels at diagnosis of immune-mediated type 1 diabetes.

Authors:  I Weets; I Truyen; I Verschraegen; B Van der Auwera; J De Schepper; H Dorchy; M-C Lebrethon; L Van Gaal; P Van Rooy; D G Pipeleers; F K Gorus
Journal:  Diabetologia       Date:  2006-03-29       Impact factor: 10.122

2.  Recent standardization of treatment strategy for pancreatic neuroendocrine tumors.

Authors:  Masayuki Imamura
Journal:  World J Gastroenterol       Date:  2010-09-28       Impact factor: 5.742

3.  Insulinoma and anaesthetic implications.

Authors:  Jyotsna Goswami; Pallavi Somkuwar; Yogesh Naik
Journal:  Indian J Anaesth       Date:  2012-03

4.  Indices of insulin sensitivity and secretion from a standard liquid meal test in subjects with type 2 diabetes, impaired or normal fasting glucose.

Authors:  Kevin C Maki; James M McKenney; Mildred V Farmer; Matthew S Reeves; Mary R Dicklin
Journal:  Nutr J       Date:  2009-05-28       Impact factor: 3.271

5.  Pitfalls in diagnosing a small cystic insulinoma: a case report.

Authors:  Mirjana Sumarac-Dumanovic; Dragan Micic; Miodrag Krstic; Maja Georgiev; Aleksandar Diklic; Svetislav Tatic; Danica Stamenkovic-Pejkovic; Aleksandra Kendereski; Goran Cvijovic; Aleksandra Pavlovic
Journal:  J Med Case Rep       Date:  2007-12-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.